Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medical Device

Alfa acquires Anagen's AuraFlex:

This article was originally published in Clinica

  • News

Executive Summary

Italian pharmaceutical company Alfa Wassermann has acquired Anagen's AuraFlex automated immunoassay system for an undisclosed amount. UK company Anagen recently went into voluntary liquidation. Alfa Biotech, a wholly-owned Alfa Wassermann subsidiary, will carry on the AuraFlex project and expects to launch the product in the second quarter of 1997. AuraFlex will be marketed by two other subsidiaries of Alfa Wassermann - Alfa Biotech in Italy and Dutch company Schiapparelli Biosystems in the rest of the world.

Table

View full table

Topics

Tags:
Medical Device
Latest Headlines

Warning Letters And Close-Outs – April 2024

To Be (a device) Or Not To Be. That’s The Legal Question

US FDA Grants Teal Health’s At-Home Cervical Screening Device Breakthrough Device Designation

Netherlands Pilots New Scientific Advice Service For Clinical Trials

See All
UsernamePublicRestriction

Register

MT089829

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By